shed light on the structural difference between Rg3 stereoisomers that can lead to significant differential physiological outcome, and the (S)-isomer seems to be the more potent isomer to be developed as a promising drug for diabetic atherosclerosis.
| INTRODUCTION
Ginseng, the root of Panax ginseng C. A. Meyer, has been consumed as herbal drug in traditional oriental medicine for preventive and therapeutic purposes for over 2000 years. Ginsenosides, the pharmacological active phytochemicals of ginseng, have been demonstrated to exert beneficial effects on diabetes and cardiovascular diseases (CVDs). 1, 2 Three types of ginsenosides have been classified, protopanaxadiols (eg, Rb1, Rb2, Rh2 and Rg3), protopanaxatriols (eg, Re, Rg1 and Rg2) and oleanolic acid derivatives. 3 Structurally, ginsenosides contain a hydrophobic triterpenoid skeleton attached with hydrophilic sugar moieties or hydroxyl groups at carbon-3, carbon-6 and carbon-20, mostly existing as enantiomeric pairs. The stereoselectivity of ginsenosides on many biological effects have been reported previously. [4] [5] [6] [7] [8] [9] Recent experiments have demonstrated that ginsenoside Rg3, which contains 2 neighbouring hydroxyl groups near and on the chiral centre C-20, can act as a natural ligand of PPARc. 10 PPARc is a member of the nuclear receptor superfamily of ligand-inducible transcription factors and regulates multiple pathways involved in the development of diabetes and CVDs. 13, 14 Recent studies have implied the role of PPARc in regulating vascular smooth muscle cell (VSMC) proliferation and migration, an essential event in the development of diabetic atherosclerosis. 15, 16 Under diabetic conditions, the accumulation of hyperglycaemia-induced AGEs and activation of the receptor for AGEs (RAGE) are key factors mediating these events. [17] [18] [19] The objective of this study was to investigate stereo-selective binding of Rg3 enantiomers to PPARc based on the stereochemical structures and to explore whether differential PPARc activation by Rg3 stereoisomers could lead to differential effects on AGEsstimulated proliferation and migration of VSMCs and diabetic atherosclerosis formation.
2 | ME TH ODOLOGY
| Simulation and calculation
The initial co-ordinates of the protein were taken from the crystal structure of the PPARc-LBD complexed with the full-agonist LT160 for the complexes were calculated using the Molecular Mechanics/ Poisson-Boltzmann Surface Area (MM/PB-SA) method. 22, 23 The
Essential Dynamics Analysis (EDA) was based on the last 10-ns equilibrated trajectory for each system. The analysis followed the "Inter- 
| Animal model
All experimental procedures were performed in accordance with guidelines for Institutional Animal Care and were approved by the Animal Ethics Committee of Shandong University. Eight-week-old male ApoEÀ/À mice (n = 60) were randomly divided into the following 6 groups (n = 10 per group): non-diabetic control group, DM (di- During the 6th-10th weeks, mice were given Rg3 at a dose of 10 mg/kg i.p. once 2 days, 25 with oral gavage of GW9662 at 3 mg/kg per day. 26 
| Biochemical measurements
Serum lipid profiles, including total cholesterol, triglyceride levels and glucose concentration, were measured by enzymatic assay with the use of an automatic biochemical analyser (Roche Cobas Integra 800, Switzerland).
| Histology and immunohistochemistry
To assess overall burden and distribution of atherosclerosis, en face lesion staining with Oil Red O was performed as previously described. 27 The remaining staining involved cross sections of the aortic roots (predilection site of atherosclerosis). The sections were stained with haematoxylin and eosin (H&E) following a standard protocol of our laboratory. Haematoxylin was applied for 4 minutes followed by a 20-second differentiation in ammonia, after which eosin was applied for 20 seconds. The content of lipids and collagen of aortic plaques was detected by Oil Red O staining and Picrosirius
Red staining, respectively.
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The immunohistochemical staining was performed as previously described. 27 Sections were incubated with the primary antibodies 
| Statistical analysis
All experiments were repeated at least 3 times, and data were presented as the mean AE SEM. Statistical analysis was carried out using ANOVA followed by Tukey's post hoc test (GraphPad Software, USA). P < .05 was considered significant. (Table S1 ). The average charge-clamp distance and MM/PB-SA estimated binding energy (Table S2) , as well as the root-mean-squared fluctuation (RMSF) for each system ( Figure S1 ), all indicate that models S1 and R2 are the most probable binding modes of 20(R/S)-Rg3 enantiomers in PPARc. The orientations of the enantiomers in the 2 models were superimposed in Figure 1A .
EDA was then employed to differentiate these 2 models, and the backbone atom traces of the models are compiled in Table 1 ( Figure 4C ).
| Biochemical parameters after Rg3 treatment in vivo
The serum levels of total cholesterol, triglyceride and fasting glucose of each group are depicted in Table S3 . Total cholesterol and triglycerides levels did not differ among the diabetic apoE-/-groups. However, there was a significant reduction in fasting glucose levels in the Relative activity was quantified by densitometric analysis (n = 3; respectively). The values shown represent means AE SEM of independent assays. *P < .05, **P < .01, ***P < .001
| DISCUSSION
The importance of drug stereoselectivity is gaining greater attention in recent years, 32 and differential pharmacological effects have been reported between ginsenoside Rg3 stereoisomers. 9, 11, 12 It is because . The ratio of the atherosclerotic lesion area to the total vessel area is quantified, indicating level of atherogenesis. C, E, Haematoxylin and eosin staining of aortic sinus cryosections; the ratio of total atherosclerotic lesion area to aorta lumen area are quantified (n = 3). Scale bar: 100 lm. D, F, Representative immunohistochemical a-SMA staining and quantification of the plaque smooth muscle cell content (n = 3). Scale bar: 50 lm. The data are expressed as the mean AE SEM *P < .05, **P < .01, ***P < .001
Differential effects of the 20(R/S)-Rg3 stereoisomers on proliferation of VSMCs within plaques. A, Co-immunofluorescence staining of the aortic root for VSMCs (anti-a-SMA antibody, red) and proliferation marker PCNA (green) and a bar graph summarizing the results (n = 3). Scale bar: 20 lm. B, Western blot analysis of cyclin D1, cyclin E and PCNA protein expression within plaques. The bands are quantified by densitometric analysis. Protein expression of cyclin D1 and PCNA was normalized to b-actin, and expression of cyclin E was normalized to GADPH (n = 3, 4, and 4 for cyclin D1, cyclin E and PCNA, respectively). The results are expressed as the mean values AE SEM. *P < .05, **P < .01, ***P < .001
bond, similar to that of rosiglitazone, 33, 34 while the sterically strained binding pocket prevented the optimal interaction of 20(R)-Rg3 with There is a concern that whether reduced smooth muscle after 20
(S)-Rg3 treatment may lead to a much less stable plaque and one that is more likely to rupture and cause further damage and possibly death, we further assessed the plaque compositions. To our great relief, 20(S)-Rg3 significantly improved other compositions in the plaque (increased the intraplaque content of collagen and decreased that of lipids and macrophages), and the plaque stability was actually increased. It has been reported that PPARc agonist could block classical activation of macrophages and attenuates inflammation in diabetic atherosclerosis, thus may promote a more favourable plaque morphology. 43, 44 In addition, atherosclerosis is also affected by lipid profiles and glucose metabolism. 45, 46 There was a trend towards a decrease in blood glucose levels in the 20(S)-Rg3-treated diabetic mice, which might also contribute to its anti-atherosclerotic effects. 
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